发明名称 TRICYCLIC COMPOUND AND APPLICATION THEREOF
摘要 PROBLEM TO BE SOLVED: To provide a novel compound that has a lipoprotein-related phospholipase A2-inhibiting action and is useful for prevention and treatment of atherosclerosis, coronary syndromes such as myocardial infarction, unstable angina and the like, peripheral arterial obstruction, stroke, cerebral infarction and the like, and a medicine containing the compound. SOLUTION: The compound is represented by formula (I). In the formula, R<SP>1</SP>is an optionally substituted 5 to 10-membered aromatic group; R<SP>2</SP>is a hydrogen atom, a halogen atom, a hydroxy group, an optionally substituted 1-6C alkoxy group or the like; R<SP>3</SP>is a hydrogen atom or a halogen atom; X<SP>1</SP>is an optionally substituted 1-2C alkylene group; X<SP>2</SP>is an oxygen atom, a sulfur atom or optionally substituted methylene; and Y is an optionally substituted 1-3C alkylene group. A salt of the compound is also provided. The medicine contains the compound. COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011088847(A) 申请公布日期 2011.05.06
申请号 JP20090242880 申请日期 2009.10.21
申请人 TAKEDA CHEM IND LTD 发明人 FUKUMOTO MASAJI;SASAKI MINORU;OURA TAIICHI;HASUI TOMOAKI;FUJIMOTO JUN;KATO TOMOKO
分类号 C07D471/04;A61K31/519;A61P1/02;A61P1/04;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/00;A61P7/00;A61P7/02;A61P9/00;A61P9/06;A61P9/08;A61P9/10;A61P9/12;A61P9/14;A61P11/00;A61P11/06;A61P13/10;A61P13/12;A61P15/00;A61P17/00;A61P19/02;A61P19/08;A61P25/00;A61P25/08;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P27/02;A61P27/12;A61P27/16;A61P29/00;A61P31/04;A61P31/18;A61P35/00;A61P37/08;A61P43/00;C12N9/99;C12N15/09 主分类号 C07D471/04
代理机构 代理人
主权项
地址